releases
Original podcast series explores ideas, issues shaping health and health care
Aug. 11, 2020—Listen to Episode 1 and subscribe on your favorite platform. Vanderbilt University Medical Center is launching Vanderbilt Health DNA: Discoveries in Action, an original podcast series exploring the issues and scientific advancements shaping health, medicine and society. The series takes the listener deep into the world of health care through conversations with more than 30...
#ListenDNA Insider Clips: Episode 1 excerpts
Aug. 4, 2020—A new podcast—Vanderbilt Health DNA: Discoveries in Action—will be launching in the coming weeks.
Study shows better option for treatment of inoperable anal cancer
Jun. 24, 2020—People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.
VUMC faculty receive grant to expand LGBTQ voices in biomedical research
Jun. 24, 2020—Researchers at Vanderbilt University Medical Center’s (VUMC) Center for Biomedical Ethics & Society were recently awarded a grant from the National Human Genome Research Institute (NHGRI) of the National Institutes for Health (NIH) to explore LGBTQ+ perspectives on a range of issues related to biomedical research.
Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19
Jun. 21, 2020—The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.
TERAVOLT registry tracks outcomes of treatments among people with thoracic cancers sickened by COVID-19
Jun. 12, 2020—New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.
Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research
Jun. 9, 2020—After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.
Fleming reflects on a life of love, purpose after terminal cancer diagnosis
Jun. 4, 2020—A month before his 49th birthday, Geoffrey Fleming, MD, had a biopsy of his liver to diagnose an unidentified metastatic disease that he already knew was “something bad.”
Core principles guiding the COVID-19 response and beyond
May. 15, 2020—During a first-ever virtual leadership assembly necessitated through social distancing, Vanderbilt University Medical Center leaders answered questions about the Medical Center’s response to COVID-19 so far and what the future could hold.
VUMC’s Capra, Bastarache set for Jan. 30 Cutting-Edge Discovery Lecture
Jan. 22, 2020—The intersection of genetics and electronic health records will be discussed by two Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Thursday, Jan. 30. The lecture will begin at 4 p.m. in 208 Light Hall.
Tennessee Receives Grant from Federal Government to Address Opioid Crisis
Dec. 20, 2019—The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants.
AI’s Future Potential Hinges on Consensus: NAM Report
Dec. 18, 2019—The current explosion of investment and development in health care AI is happening without an underpinning of consensus of responsible, transparent deployment, which potentially constrains its potential.
